Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Aradigm to Present Additional ORBIT-2 Clinical Trial Results at Respiratory Drug Delivery Europe 2011 Conference.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • الموضوع:
    • الموضوع:
    • الموضوع:
    • نبذة مختصرة :
      The article reports that Aradigm Corp.'s senior director of pharmaceutical sciences David Cipolla will present the company's clinical trial results at the Respiratory Drug Delivery Europe 2011 Conference, which is held in Berlin, Germany. It notes that the statistical analysis of the results of the ORBIT-2 trial will also be included in the presentation. Moreover, the reduction from baseline in Pseudomonas aeruginosa colony forming units (CFUs) has concluded the analysis.